It gives us great pleasure to welcome you to the Fifth Annual Pediatric Pharmacogenomics and Personalized Medicine Conference. This meeting will be focused on Genome Based Therapeutics in Children. This sharing of knowledge will serve as a forum for world leaders in the field to come together to contribute to the safe and effective treatment of children, our most vulnerable population. We have developed an excellent program featuring speakers from around the world to share with you the latest opportunities centering around clinical applications, bioethics, bioinformatics, and infrastructure development of pediatric personalized medicine programs. Take a few moments to browse the program to confirm our assertions that the presentations feature a world-class group of experts that will make excellent use of our brief time together. Please join us as we celebrate the offerings of science and exchanges that will affect our practices long after the end of this meeting in the form of new energy and ideas that will boost our efforts to improve the health of our children. As we continue to expand our initiatives here at Children’s Mercy, we also continue to expand our collaborative efforts with other researchers regionally, nationally and internationally. We hope you, our colleagues, will join us in these efforts. We expect attendance will be strong and look forward to seeing you in April in Kansas City, MO.
J Steven Leeder, PharmD, PhD
Gregory L Kearns, PharmD, PhD
John Lantos, MD
Session Topics Include:
"Personalized/Individualized Medicine: The Role of Networks and Academic Parternships"
"The role of pharmacogenomics in determining the effect of drugs used to treat asthma and allergic disease"
"The role of pharmacogenomics in determining the effect of drugs used in cancer and/or infectious disease"
"ADHD and Autism pharmacogenetics"
"EMA position on the inclusion of pharmacogenetic/genomic data into product labels"
"The clinical use of genetics in pediatrics"
"Genetic screening (either prenatal or postnatal) to develop enhancement programs"
"Electronic Health Record-based Phenotyping in a Pediatric Setting: A Case Study for Drug Induced Liver Injury."
"Physiologically-Based Pharmacokinetic (PBPK) Models in Children: Data In, Knowledge Out"
"Clinical Use of Whole Genome Sequencing: The Challenges Ahead"
Dick Weinshilboum, MD
Donald R Mattison, MD
Risk Sciences International Ottawa, ON
Casey L Overby, PhD
University of Maryland School of Medicine
Bridgette L Jones, MD
Allergy/Immunology & Clinical Pharmacology
Howard L McLeod, PharmD
Moffitt Cancer Center, Florida
Erika Nurmi, MD, PhD
Semel Institute for Neuroscience, University of California
Agnes Saint-Raymond, MD
Ethics Head of Programme Board European Medicines Agency
Steve Joffe, MD, MPH
University of Pennsylvania, Perelman School of Medicine
Hank Greely, JD
Sanford Law School
Sigrid Sterckx, Professor
BioEthics Institute Ghent, Ghent University and Vrije Universiteit Brussel
Andrea Edginton, PhD
School of Pharmacy at the University of Waterloo
National Institutes of Health
Funding for this conference was made possible [in part] by 2R13HD065386 from National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government